Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Stahl (Heidelberg, Germany), M. Wielpuetz (Heidelberg, Germany), I. Ricklefs (Lübeck, Germany), S. Graeber (Heidelberg, Germany), O. Sommerburg (Heidelberg, Germany), G. Diekmann (Lübeck, Germany), C. Dopfer (Hannover, Germany), S. Barth (Giessen, Germany), A. Schlegtendal (Bochum, Germany), C. Koerner-Rettberg (Bochum, Germany), L. Naehrlich (Giessen, Germany), B. Tuemmler (Hannover, Germany), M. Kopp (Lübeck, Germany), M. Mall (Heidelberg, Germany). Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS). 513

Member's Comments

No comment yet.

Related content which might interest you: Nebulised hypertonic (7%) saline improves quality of life in a blinded randomised cross-over trial Source: Annual Congress 2010 - Management of airway disease Year: 2010 Inhaled racemic adrenalin versus saline in acute bronchiolitis, a multicenter randomized double-blind clinical trial Source: Annual Congress 2012 - New insights into respiratory infections in children Year: 2012 A randomised, placebo-controlled trial of inhaled mannitol in patients with bronchiectasis Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008 RCT Abstract - Randomized, double-blind, placebo-controlled, phase III clinical trial with MV130, a sublingual bacterial immunotherapy to prevent COPD exacerbations Source: Virtual Congress 2021 – ALERT: COPD Year: 2021 Randomised, double-blind, placebo-controlled trial of EPS® 7630 in adults with COPD Source: Annual Congress 2009 - Healthcare and treatment of COPD Year: 2009 Effectiveness of influenza vaccination in asthmatic children: randomised, double-blind, placebo-controlled trial Source: Eur Respir J 2002; 20: Suppl. 38, 146s Year: 2002 A multicenter, randomized, double-blind, double-dummy, 2-way crossover, single dose study, comparing the efficacy and safety of the fluticasone/salmeterol (500/50 μg) combination administered with the new Elpenhaler inhalation device versus the innovative one in patients with asthma Source: Annual Congress 2009 - Quality of treatment in primary respiratory care Year: 2009 A double-blind trial of hyperosmolar saline as an adjunt to phsiotherapy in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 484s Year: 2001 PRAISE, a randomized, placebo-controlled, double-blind Phase 2 clinical trial of pamrevlumab (FG-3019) in IPF patients Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights Year: 2017 Omalizumab efficacy following cat allergen exposure: Results from a randomized, double-blind, placebo-controlled, parallel-group study in patients with moderate asthma Source: Annual Congress 2010 - Asthma: clinical aspects and treatment Year: 2010 Efficacy and safety of revefenacin (REV), a long-acting muscarinic antagonist for nebulization: results of replicate randomized, double-blind, placebo-controlled, parallel-group phase 3 trials in participants with moderate to very severe COPD Source: International Congress 2017 – Bronchodilators and bronchoprotectors Year: 2017 A double-blind double dummy randomised placebo-controlled cross-over design clinical trial of formoterol delivered by two different dry powder devices in prevention of bronchoconstriction induced by methacholine in mild to moderate persistent asthma in adult patients Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment Year: 2009 The efficacy and safety of topical phenylephrine before flexible bronchoscopy: a double-blind, randomized controlled trial Source: Annual Congress 2008 - News from diagnostic bronchoscopy Year: 2008 Acetazolamide administration following upper airway surgery for SDB. Preliminary results of a randomized, double-blind, placebo-controlled study Source: Eur Respir J 2005; 26: Suppl. 49, 201s Year: 2005 A phase-III multicenter, randomized, double-blind, controlled trial of high-dose inhaled nitric oxide in infants with acute bronchiolitis. Source: International Congress 2018 – Paediatric respiratory infections: mechanistic insights and clinical outcomes Year: 2018 Recombinant human deoxyribonuclease (rhDNase) for the treatment of acute asthma in children: a multicentre randomised double-blind clinical trial Source: Annual Congress 2007 - Childhood asthma: treatment and follow-up Year: 2007 Randomised double blind placebo controlled trial of selenium supplementation in adult asthma Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006 Working memory training efficacy in COPD: the randomised, double-blind, placebo-controlled Cogtrain trial Source: ERJ Open Res, 7 (4) 00475-2021; 10.1183/23120541.00475-2021 Year: 2021 Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19 Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19 Year: 2021